» Articles » PMID: 39634517

Noninvasive Anatomical Assessment for Ruling out Hemodynamically Relevant Coronary Artery Anomalies in Adults - A Comparison of Coronary-CT to Invasive Coronary Angiography: The NARCO Study Design

Abstract

Background: Anomalous aortic origin of a coronary artery (AAOCA) is a rare congenital heart disease, potentially leading to myocardial ischemia and adverse cardiac events. As the sole presence of AAOCA does not always imply a revascularization, a detailed anatomical and functional analysis is crucial for clinical decision-making. Currently, invasive coronary angiography is the gold-standard method for a thorough hemodynamic assessment of AAOCA. However, due to its invasive nature, the development of noninvasive diagnostic alternatives is desired.

Methods: In the NARCO trial, patients with AAOCA will undergo coronary computed tomography angiography (CCTA) to assess anatomical high-risk features followed by a vessel-based (i.e. invasive measurement with fractional flow reserve and intravascular imaging under a dobutamine-volume challenge) and a myocardium-based (i.e. nuclear imaging) ischemia testing. Comparison of noninvasive and invasive imaging will be performed. Additionally, explorative analysis of post-processing advanced computational fluid dynamics (CFD) and 3D printing will be performed to unravel the pathophysiologic mechanism of myocardial ischemia in AAOCA.

Aims: Our primary aim is to define characteristics of anatomical high-risk features (using CCTA) to rule out noninvasively hemodynamically relevant anomalous vessels in AAOCA patients. The secondary aim is to investigate the underlying pathophysiology of AAOCA-related hemodynamic relevance using advanced techniques such as CFD and 3D printing.

Conclusions: The NARCO trial will help to optimize AAOCA patient selection for revascularization by improving risk stratification and ruling out hemodynamic relevance noninvasively and, therefore, preventing unnecessary downstream testing and/or costly interventions in patients with AAOCA.

References
1.
Stark A, Giannopoulos A, Pugachev A, Shiri I, Haeberlin A, Raber L . Application of Patient-Specific Computational Fluid Dynamics in Anomalous Aortic Origin of Coronary Artery: A Systematic Review. J Cardiovasc Dev Dis. 2023; 10(9). PMC: 10532130. DOI: 10.3390/jcdd10090384. View

2.
Pijls N, van Gelder B, van der Voort P, Peels K, Bracke F, Bonnier H . Fractional flow reserve. A useful index to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow. Circulation. 1995; 92(11):3183-93. DOI: 10.1161/01.cir.92.11.3183. View

3.
Grani C, Benz D, Schmied C, Vontobel J, Possner M, Clerc O . Prevalence and characteristics of coronary artery anomalies detected by coronary computed tomography angiography in 5 634 consecutive patients in a single centre in Switzerland. Swiss Med Wkly. 2016; 146:w14294. DOI: 10.4414/smw.2016.14294. View

4.
Jiang M, Khan M, Ghobrial J, Rogers I, Pettersson G, Blackstone E . Patient-specific fluid-structure simulations of anomalous aortic origin of right coronary arteries. JTCVS Tech. 2022; 13:144-162. PMC: 9196314. DOI: 10.1016/j.xjtc.2022.02.022. View

5.
Gaudino M, Di Franco A, Arbustini E, Bacha E, Bates E, Cameron D . Management of Adults With Anomalous Aortic Origin of the Coronary Arteries: State-of-the-Art Review. J Am Coll Cardiol. 2023; 82(21):2034-2053. DOI: 10.1016/j.jacc.2023.08.012. View